| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/18/2007 | WO2007028513A3 Application system for a plaster containing an active ingredient and a controlled-release agent for said active ingredient |
| 05/18/2007 | WO2007028083A3 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 05/18/2007 | WO2007025540A3 Substituted imidazo[1,2b]pyridazines as kinase inhibitors, the production thereof, and use of the same as medicaments |
| 05/18/2007 | WO2007025094A3 Stabilized and preserved ketotifen ophthalmic compositions |
| 05/18/2007 | WO2007025089A3 Triazole compounds and methods of making and using the same |
| 05/18/2007 | WO2007024611A3 Sulfonamides of 7 -aminoheptanoic acid derivatives for treating glaucoma |
| 05/18/2007 | WO2007023154A3 Iron (iii) complex compounds for treating iron deficiency in patients with chronic inflammatory intestinal diseases |
| 05/18/2007 | WO2007023111A3 P38 map kinase inhibitors and methods for using the same |
| 05/18/2007 | WO2007023073A3 Bicyclic heterocycles medicaments comprising said compounds use and method for production thereof |
| 05/18/2007 | WO2007020631A3 Tetracyclic benzofuran derivatives with therapeutic activities |
| 05/18/2007 | WO2007019865A3 Therapy with cd4 binding peptides and radiation |
| 05/18/2007 | WO2007018622A3 Vaginal treatment composition |
| 05/18/2007 | WO2007017695A3 Dihydroxyanthraquinones and their use |
| 05/18/2007 | WO2007015157A3 Mc4r-ag0nists for the treatment of urinary tract dysfunction |
| 05/18/2007 | WO2007014934A8 Quinoline derivatives as antibacterial agents |
| 05/18/2007 | WO2007014566A3 Microcapsules and their use |
| 05/18/2007 | WO2007013556A8 Composition for prevention of cancer |
| 05/18/2007 | WO2007011765A3 Methods of identifying and treating individuals exhibiting mutant src kinase polypeptides |
| 05/18/2007 | WO2007011647A3 Inhibitors of mitotic kinesin ksp |
| 05/18/2007 | WO2007008072A3 CROSS-ß STRUCTURE BINDING COMPOUNDS |
| 05/18/2007 | WO2007008069A3 A method for detecting peptides comprising a cross-b structure |
| 05/18/2007 | WO2007006550A3 Oligomers of straight-chain and unbranched fatty acids, and medicaments containing the same |
| 05/18/2007 | WO2007006544A3 Cyclic adenosine monophosphate compounds for the treatment of immune-related disorders |
| 05/18/2007 | WO2007002313A3 Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants |
| 05/18/2007 | WO2007001961A3 Method for the treatment of acne |
| 05/18/2007 | WO2007000340A8 Bicyclic derivatives as p38 kinase inhibitors |
| 05/18/2007 | WO2006138641A3 Manufacturing process for tigecycline |
| 05/18/2007 | WO2006138259A3 Chemokine receptor binding compounds |
| 05/18/2007 | WO2006136916A3 Substantially pure micronized particles of telmisartan and pharmaceutical compositions containing same |
| 05/18/2007 | WO2006128179A3 Use of matrilin-1 for the treatment of angiogenesis related diseases |
| 05/18/2007 | WO2006127458A3 Novel chemical compounds |
| 05/18/2007 | WO2006125555A3 Quinazolinones |
| 05/18/2007 | WO2006118948A3 Therapeutic compositions |
| 05/18/2007 | WO2006112703A3 Induction of omega-oxidation of fatty acids by cytochrome p450 for counteracting fatty acid accumulation |
| 05/18/2007 | WO2006109085A8 Hydroxybenzamide derivatives and their use as inhibitors of hsp90 |
| 05/18/2007 | WO2006106438A3 Modulators of ppar activity |
| 05/18/2007 | WO2006099058A3 Organic nitric oxide enhancing salts of angiotensin ii antagonists, compositions and methods of use |
| 05/18/2007 | WO2006096405A3 Treatment of amyotrophic lateral sclerosis with pyrimethamine and analogues |
| 05/18/2007 | WO2006089309A3 Method of treating atherosclerosis, dyslipidemias and related conditions |
| 05/18/2007 | WO2006089012A3 Device for delivery of trpv1 agonists |
| 05/18/2007 | WO2006081323A3 Anti-cancer dna vaccine employing plasmids encoding mutant oncoprotein antigen and calreticulin |
| 05/18/2007 | WO2006079119A9 Modulation of th2 lineage commitment by t-bet |
| 05/18/2007 | WO2006071351A3 Synergistic effect of amlodipine and atorvastatin on aortic endothelial cell nitric oxide release |
| 05/18/2007 | WO2006062748A3 Omega-3 fatty acids and dyslipidemic agent for lipid therapy |
| 05/18/2007 | WO2006041635A8 Arylthiobenzylpiperidine derivatives |
| 05/18/2007 | WO2006036278A8 THERAPEUTIC AGENTS TARGETING THE NCCa-ATP CHANNEL AND METHODS OF USE THEREOF |
| 05/18/2007 | WO2006035244A8 Ecteinascidin compounds as anti -inflammatory agents |
| 05/18/2007 | WO2006034474A3 Novel pyridine compounds, process for their preparation and compositions containing them |
| 05/18/2007 | WO2006030439A3 Compositions and methods for inducing hair growth |
| 05/18/2007 | WO2006028525A3 [3.2.0] heterocyclic compounds and methods of using the same |
| 05/18/2007 | WO2006024955A8 Azabicyclic amine histamine-3 receptor antagonists |
| 05/18/2007 | WO2006018842A3 Inhibitors of p38-alpha kinase |
| 05/18/2007 | WO2006015775A3 Egfr kinase inhibitor combinations for treating respiratory and gastrointestinal disorders |
| 05/18/2007 | WO2005062880A3 Wound dressing and method for controlling severe, life-threatening bleeding |
| 05/18/2007 | WO2005018435A3 Thermally modified microbial-derived cellulose for in vivo implantation |
| 05/18/2007 | WO2005011603A3 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
| 05/18/2007 | WO2003076594A3 Genomic screen for epigenetically silenced tumor suppressor genes |
| 05/18/2007 | CA2833852A1 Quinazoline derivatives for the treatment of cancer diseases |
| 05/18/2007 | CA2833706A1 Quinazoline derivatives for the treatment of cancer diseases |
| 05/18/2007 | CA2669736A1 Heterocyclic compounds as tyrosine kinase modulators |
| 05/18/2007 | CA2637806A1 Compositions for regulating metabolic disorders and methods of use thereof |
| 05/18/2007 | CA2636596A1 Method of treating cancers with saha and pemetrexed |
| 05/18/2007 | CA2632931A1 Use of cicletanine and other furopyridines for treatment of hypertension |
| 05/18/2007 | CA2632697A1 Treatment of mitochondria-related diseases and improvement of age-related metabolic deficits |
| 05/18/2007 | CA2630023A1 Cancer antigen mage-a9 and uses thereof |
| 05/18/2007 | CA2629864A1 N-sulfamoyl-n'-benzopyranpiperidines as inhbitors of carbonic anhydrases |
| 05/18/2007 | CA2629770A1 Thiazole analogues and uses thereof |
| 05/18/2007 | CA2629478A1 Staurosporine derivatives for use in alveolar rhabdomyosarcoma |
| 05/18/2007 | CA2629375A1 Compositions of cis-9, trans-11 conjugated linoleic acid and vaccenic acid and uses thereof |
| 05/18/2007 | CA2629367A1 Use of pde iii inhibitors and/or calcium sensitizers for the treatment of asymptomatic (occult) heart failure |
| 05/18/2007 | CA2629337A1 Use of angeloyl-substituted ingenanes in combination with other agents to treat cancer |
| 05/18/2007 | CA2629327A1 Pharmaceutical compositions comprising polymeric binders with non-hydrolysable covalent bonds and their use in treating celiac disease |
| 05/18/2007 | CA2629298A1 Anti-proliferative combination therapy comprising a platinum-based chemotherapeutic agent and egfr inhibitors or pyrimidine analogues |
| 05/18/2007 | CA2629258A1 Azonafide derivatives, methods for their production and pharmaceutical compositions therefrom |
| 05/18/2007 | CA2629249A1 Combination treatment of cancer comprising egfr/her2 inhibitors |
| 05/18/2007 | CA2629244A1 Quinazoline derivatives for the treatment of cancer diseases |
| 05/18/2007 | CA2629237A1 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 05/18/2007 | CA2629228A1 Pyrrolopyridines as kinase inhibitors |
| 05/18/2007 | CA2629199A1 Compositions and methods for the treatment of addiction and other neuropsychiatric disorders |
| 05/18/2007 | CA2629136A1 .alpha.-helix mimetics and method relating to the treatment of cancer stem cells |
| 05/18/2007 | CA2629018A1 Aza-substituted spiro derivative |
| 05/18/2007 | CA2628971A1 Therapeutic or prophylactic agent for functional bowel disorder |
| 05/18/2007 | CA2628941A1 Methods for the identification of microrna and their applications in research and human health |
| 05/18/2007 | CA2628937A1 Tetracyclic indole derivatives as antiviral agents |
| 05/18/2007 | CA2628936A1 Thiazolo [4 , 5-c] pyridine derivatives as mglu5 receptor antagonists |
| 05/18/2007 | CA2628934A1 Tetrahydroindole derivatives for treatment of alzheimer's disease |
| 05/18/2007 | CA2628881A1 Diaryl urea for treating diabetic neuropathy |
| 05/18/2007 | CA2628875A1 Diaryl ureas for treating diabetic neuropathy |
| 05/18/2007 | CA2628856A1 Indene derivatives, their preparation and use as medicaments |
| 05/18/2007 | CA2628849A1 Diaryl urea for treating pulmonary hypertension |
| 05/18/2007 | CA2628848A1 Compositions and methods for treating thrombocytopenia |
| 05/18/2007 | CA2628847A1 Diaryl ureas for treating pulmonary hypertension |
| 05/18/2007 | CA2628718A1 Polycationic viscoelastic compositions |
| 05/18/2007 | CA2628667A1 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives |
| 05/18/2007 | CA2628624A1 Indole derivatives as antitumoural compounds |
| 05/18/2007 | CA2628570A1 Methods, compositions, and kits for the treatment of medical conditions |
| 05/18/2007 | CA2628534A1 Methods for inhibiting protein kinases |
| 05/18/2007 | CA2628509A1 Viscoelastic compositions comprising polycationic quaternary ammonium compounds |
| 05/18/2007 | CA2628508A1 Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy |
| 05/18/2007 | CA2628506A1 Combinations of metformin and meglitinide |